<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-86667</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The use of oral lacosamide in a patient with refractory partial epileptic status</dc:title>
<dc:description xml:lang="en">Introduction. Generalised epileptic status is a medical emergency with a well-defined therapeutic algorithm. Nevertheless, in the partial status, treatment must be tailored to each patient and the risk of intensive treatment has to be assessed. Unlike generalised epileptic status, partial status is not considered a medical emergency, which means that when it comes  to choosing a type of treatment the risk-benefit ratio must be carefully evaluated bearing in mind the characteristics of each particular case. Case report. A 72-year-old male with partial status secondary to an ischaemic lesion which was refractory to conventional treatment; treatment was established with lacosamide and his condition was rapidly inverted. This is the third case that has been reported of epileptic status being treated with this drug and the second in which it is employed orally.  Conclusions. Although further research is required, lacosamide could be a good therapeutic option with few interactions and side effects (AU)</dc:description>
<dc:creator>Turpín Fenoll, Laura</dc:creator>
<dc:creator>Millán Pascual, Jorge</dc:creator>
<dc:creator>Rueda Medina, Ignacio</dc:creator>
<dc:creator>del Saz Saucedo, Pablo</dc:creator>
<dc:creator>Navarro Muñoz, Santiago</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. El estado epiléptico generalizado es una urgencia médica con un algoritmo terapéutico bien definido. Sin embargo, en el estado parcial, el tratamiento debe individualizarse y valorar el riesgo del tratamiento intensivo. A diferencia del estado epiléptico generalizado, el estado parcial no se considera una emergencia médica, por lo que en la  elección de su tratamiento debe valorarse cuidadosamente y de modo individualizado la relación riesgo-beneficio.Caso clínico. Varón de 72 años con estado parcial secundario a lesión isquémica y refractario a tratamiento convencional,  en el que se inicia tratamiento con lacosamida y se consigue su rápida reversión. Se trata del tercer caso de estado epiléptico publicado con este fármaco y del segundo en el que se emplea vía oral. Conclusión. Aunque se requieren más estudios la lacosamida podría representar una buena opción terapéutica con escasas interacciones y efectos secundarios (AU)</dc:description>
<dc:source>Rev Neurol;50(10): 603-606, mayo 2010. ilus</dc:source>
<dc:identifier>ibc-86667</dc:identifier>
<dc:title xml:lang="es">Uso de lacosamida oral en un paciente con estado epiléptico parcial refractario</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d934^s22079</dc:subject>
<dc:subject>^d13612^s22057</dc:subject>
<dc:subject>^d23025^s22079</dc:subject>
<dc:subject>^d2585^s22057</dc:subject>
<dc:subject>^d23405</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d13024^s22057</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:type>article</dc:type>
<dc:date>201005</dc:date>
</metadata>
</record>
</ibecs-document>
